ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

ConvaTec Group Plc

Cymed MicroSkin manufactures and distributes ostomy pouching systems featuring MicroSkin adhesives, which are transparent, hypoallergenic polyurethane films designed for comfort and security in ostomy care.

Cymed MicroSkin

Inflix Pharma is involved in the development of specialty products for diabetes care, including sugar substitutes.

Inflix Pharma

Zimmer Biomet develops and provides medical technology solutions aimed at alleviating pain and improving the quality of life for people around the world. Self-described as committed to advancing healthcare through cutting-edge technology.

Zimmer Biomet

ConvaTec is a medical products and technologies company that develops, manufactures, and markets products for the management of chronic conditions, with a focus on advanced wound care, ostomy care, continence and critical care, and infusion care.

ConvaTec

Convatec Infusion Care

Convatec Ostomy Care

Convatec Nederland

Flexi-Seal™ Fecal Management System

Convatec Continence Care

Convatec Wound

Clínica ConvaCare

At Convatec, #ForeverCaring is our promise to patients & healthcare providers, as we deliver pioneering trusted medical solutions to improve the lives we touch. 

#ForeverConvatec

Convatec

Hidden health conditions are not always immediately obvious to others, but the more you understand about them, the more people feel seen. 

At Convatec we are on a journey to Forever caring, find out more here: https://lnkd.in/eUKmshiy 

#ForeverCaring #ForeverConvatec #HiddenHealthConditions

This week, colleagues at our largest UK manufacturing site in Deeside, north Wales were pleased to host a visit from the local Member of Parliament, the Rt Hon Mark Tami. During his visit, Mark met colleagues and was given a demonstration of our different products and solutions in advanced wound care, as well as a tour of our facilities including our textile line and new clean room.
 
Our CFO Jonny Mason and UK manufacturing site leader Adeel Mushtaq enjoyed hosting Mark, alongside other leaders in research and development and operations. Mark was also able to spend time with several of our apprentices and summer interns to hear more about how our teams are bringing to life our vision of pioneering trusted medical solutions to improve the lives we touch. 

#ForeverCaring #ForeverConvatec #WeAreConvatec #Deeside

Today, on World Humanitarian Day, we recognise the important role of humanitarian workers in delivering life-saving support and protection to those who need it most. 

In line with our forever caring promise, we also support humanitarian partners who serve vulnerable populations in our communities. This year we contributed to relief efforts around the catastrophic flooding in South Brazil, and the devastating earthquake in Japan. We also continued to support our charity partners working in Ukraine, with additional product donations bringing our total contribution to over $2 million.

In addition, we take this moment to thank our global charity partner, Partners In Health (PIH). Through our partnership, PIH has facilitated the training and equipping of hundreds of Community Health Workers (CHW), which by extension, have touched the lives of thousands of people. 

#WorldHumanitarianDay #ConvateCares #PIH 
#WeAreConvatec #ForeverCaring #ForeverConvatec

Hidden health conditions are more common than you may think, and many people don’t know much about them at all.
 
Find out more about how Convatec can support you here: https://lnkd.in/eUKmshiy
 
#ForeverCaring #ForeverConvatec #HiddenHealthConditions

Starting your treatment doesn’t have to stop you from doing the things you love. Re-define your diagnosis.
 
#ForeverCaring #ForeverConvatec

Metric
Company Name	ConvaTec Group Plc	Cymed MicroSkin	Inflix Pharma	Zimmer Biomet
Symbol	CTEC
MSH ID	COM:CONVATECGROUP	COM:CYMEDOSTOMY	COM:INFLIXPHARMA	EU:ZIMMERBIOMET
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Consumer Goods	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Medical Devices	Pharmaceuticals	Medical Devices
Country	GB	US	IN	EU
Stage
Employee Count	10.14K
Website	convatecgroup.com	cymedostomy.com	inflixpharma.com	zimmerbiomet.eu
LinkedIn	convatec			zimmerbiomet
Founders

Metric
Market Cap	63.14M
Enterprise Value
Monthly Web Traffic		24.68K
Web Traffic Growth		-0.01
Valuation
Raised Capital

Metric
Revenue	2.14B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.20B
EBITDA	482.20M
Operating Income	262.70M
Net Income	130.30M
EPS	0.06
Diluted EPS	0.06
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.56
Operating Profit Margin	0.14
EBITDA Margin	0.23
Net Profit Margin	0.07
Return on Equity	0.09
Return on Assets	0.04
Return on Capital Employed	0.09

COM:CONVATECGROUP

ConvaTec

Last Close

235.80

25/11 09:24

Market Cap

49.54M

Beta: -

Volume Today

334.92K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	189.47
P/B Ratio	3.67
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.56
EV Multiple	13.58

Metric
Days Sales Outstanding
Days Payables Outstanding	257.98
Days Inventory Outstanding	159.32
Operating Cycle	230.09
Cash Conversion Cycle	146.81
Asset Turnover	0.61

Metric
Operating Cash Flow	367.40M
Free Cash Flow	238.20M
Cash Flow to Debt	0.28
Operating Cash Flow/Sales	0.17
Free Cash Flow Yield	0.01

Metric
Cash & Equivalents	97.60M
Accounts Receivable
Inventory	396.10M
Goodwill	1.30B
Debt to Capitalization	0.46
Debt to Assets	0.39
Current Ratio	1.70
Quick Ratio	1.27

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue	0.04
SG&A to Revenue	0.38